首页 | 本学科首页   官方微博 | 高级检索  
     


Successful Treatment of Kasabach-Merritt Syndrome with Prednisone and Epsilon-Aminocaproic Acid
Authors:Marie-Francoise Dresse   Michele David  Heather Hume  Herve Blanchard  Pierre Russo  Nicolas Van Doesberg  Georges E. Rivard
Affiliation:Hematology-Oncology, H?pital Sainte-Justine, Montreal, Quebec, Canada.
Abstract:The Kasabach-Merritt syndrome is characterized by thrombocytopenia and localized coagulopathy associated with a hemangioma. Most techniques applied to eradicate the tumor or accelerate its involution (surgery, radiation therapy, embolization) are invasive and require transfusion of large amounts of blood products. In some cases, medical treatment is the only alternative. Efficacy of steroids and antifibronolytic agents has already been described, but even this approach is associated with the administration of blood products. We report two cases of infants with Kasabach-Merritt syndrome associated with cardiac and hepatic hemangiomas. At admission, both had signs of cardiac failure. They were successfully treated with prednisone and epsilon-aminocaproic acid (EACA). Blood products were not required once the diagnosis was made. These observations have important implications for the management of patients with Kasabach-Merritt syndrome because they show that even in severe cases blood transfusions can be avoided by the use of prednisone and EACA.
Keywords:antifibrinolytic agents  epsilon-aminocaproic acid  hemangioma  Kasabach-Merritt syndrome  steroids
本文献已被 InformaWorld 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号